{
  "id": "366ddba51cd65bd0",
  "title": "Alpha Buying : Managing Biotech Risk With Insider Clues - Annexon ( NASDAQ : ANNX ), CervoMed ( NASDAQ : CRVO ) ",
  "description": "20260115T170000Z",
  "content": "",
  "source": "benzinga.com",
  "source_url": "https://www.benzinga.com/opinion/26/01/49941880/alpha-buying-managing-biotech-risk-with-insider-clues",
  "published_at": "20260115T170000Z",
  "fetched_at": "2026-01-16T00:24:08.160649+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "aging"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.benzinga.com/opinion/26/01/49941880/alpha-buying-managing-biotech-risk-with-insider-clues",
    "url_mobile": "",
    "title": "Alpha Buying : Managing Biotech Risk With Insider Clues - Annexon ( NASDAQ : ANNX ), CervoMed ( NASDAQ : CRVO ) ",
    "seendate": "20260115T170000Z",
    "socialimage": "https://cdn.benzinga.com/files/images/story/2026/01/15/Stock-Market-Analysis-With-Candlestick-C.jpeg?&fit=crop",
    "domain": "benzinga.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}